ImageneBio Inc (IMA) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of ImageneBio Inc and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMA
ImageneBio Inc
$4.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PDSB
PDS Biotechnology Corporation
$1.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IMA vs PDSB
growth of $100 · dividends reinvested · last 6yIMA -98.8% (-52.0%/yr)PDSB -73.0% (-19.6%/yr)PDSB compounded faster over this window
Log scale — wide-divergence pair
IMA PDSB
IMA vs PDSB: by the numbers
- •PDSB is the larger company ($58M vs $52M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | IMA | PDSB |
|---|---|---|
| P/B ratio | 0.37 | N/A |
Profitability
| Metric | IMA | PDSB |
|---|---|---|
| Gross margin | -29.12% | 0.00% |
| Operating margin | -6056.37% | 0.00% |
| Net margin | -5668.62% | 0.00% |
| ROE | -36.94% | N/A |
| ROIC | -40.53% | -3699.99% |
Growth (annualized)
| Metric | IMA | PDSB |
|---|---|---|
| Total return CAGR (5Y) | -50.73% | -39.13% |
Frequently asked
- How have IMA and PDSB total returns compared?
- Over the past 5 years, IMA delivered -50.73% and PDSB delivered -39.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.